Personnel exposure during gamma endovascular brachytherapy

Health Physics

Volumn 79, Issue 2, 2000, Pages 136-146

  Balter, S ^b   Oetgen, M ^b   Hill, A ^b   Dalton, J ^b   Sacher, A ^b   Lipsztein, R ^b   Collins, M ^b   Moses, J ^a  

^a Lenox Hill Heart/Vascular Institute   (United States)

^b NONE

Author keywords

192Ir; Brachytherapy; Exposure; Gamma radiation; Occupational

Indexed keywords

ARTICLE; BRACHYTHERAPY; DOSIMETRY; GAMMA RADIATION; HEALTH CARE PERSONNEL; HEART CATHETERIZATION; MONITORING; OCCUPATIONAL EXPOSURE; PERSONNEL RADIATION MONITORING; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0033926924     PISSN: 00179078     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004032-200008000-00006     Document Type: Article

References (16)

1. AAPM. Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. Med Phys. 22:209-234; 1995.
2. Amols, H. I. Intervascular brachytherapy physics. In: Waksman, R., ed. Vascular brachytherapy. Armonk, NY: Futura Publishing; 1999: 177-190.
3. Amols, H. I.; Zaider, M.; Weinberger, J.; Ennis, R.; Schiff, P. B.; Reinstein, L. E. Dosimetric considerations for catheter-based beta and gamma emitters in the therapy of neointimal hyperplasia in human coronary arteries. Int. J. Radiat. Oncol. Biol. Phys. 36:913-921; 1996.
4. Balter, S. Endovascular brachytherapy: physics and technology. Cathet. Cardiovasc. Diagn. 45: 292-298; 1998.
5. Baiter, S. Endovascular brachytherapy: A health physics perspective. In: Waksman, R., ed. Vascular brachytherapy. Armonk, NY: Futura Publishing; 1999: 191-203.
6. Bass, B. G. Radiation safety requirements for vascular radiotherapy in the catheterization laboratory. In: Waksman, R., ed. Vascular brachytherapy. Armonk, NY: Futura Publishing; 1999: 581-592.
7. Califf, R. M. Restenosis: the cost to society. Am. Heart J. 130: 680-684; 1995.
8. 192Ir ribbons. Semin. Interv. Cardiol. 2:119-123; 1997.
9. Lehmann, K. G.; Melkert, R.; Surruys, P. W. Contributions of frequency distribution analysis to the understanding of coronary restenosis. A reappraisal of the gaussian curve. Circulation 93:1123-1132; 1996.
10. Levine, G. N.; Chodos, A. P.; Loscalzo, J. Restenosis following coronary angioplasty: clinical presentations and therapeutic options. Clin. Cardiol. 18:693-703; 1995.
11. Mintz, G. S.; Hoffmann, R.; Mehran, R.; Pichard, A. D.; Kent, K. M.; Satler, L. F.; Leon, M. B. In-stent restenosis: the Washington Hospital Center experience. Am. J. Cardiol. 81(7A):7E-13E; 1998a.
12. Mintz, G. S.; Mehran, R.; Waksman, R.; Pichard, A. D.; Kent, K. M.; Satler, L. F.; Leon, M. B. Treatment of in-stent restenosis. Semin. Interv. Cardiol. 3:117-121; 1998b.
13. National Council on Radiation Protection and Measurements. Structural shielding design and evaluation for medical use of x-rays and gamma rays of energies up to 10 MeV. Washington, DC: NCRP; Report 49; 1976.
14. National Council on Radiation Protection and Measurements. Use of personal monitors to estimate effective dose equivalent and effective dose to workers for external exposure to LOW-LET radiation. Bethesda, MD: NCRP; Report 122; 1995.
15. Teirstein, P. S. Prevention of vascular restenosis with radiation. Tex. Heart Inst. J. 25:30-33; 1998.
16. Waksman, R. Intracoronary radiation therapy for resteosis: The clinical trials. In: Waksman, R., eds. Vascular brachytherapy. Armonk, NY: Futura Publishing; 1999: 435-447.